| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/2004 | CN1469749A Use of antiprogestins for the induction of apoptosis in a cell |
| 01/21/2004 | CN1469748A Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 01/21/2004 | CN1469747A Use of triazinetrione sulfoxides for controlling coccidioses |
| 01/21/2004 | CN1469746A A retroviral immunotherapy |
| 01/21/2004 | CN1469745A Preventives and remedies for complications of diabetes |
| 01/21/2004 | CN1469744A Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 01/21/2004 | CN1469743A 雌激素受体调节剂 Estrogen receptor modulators |
| 01/21/2004 | CN1469742A Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
| 01/21/2004 | CN1469741A Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts |
| 01/21/2004 | CN1469740A Composition for improving lipid metabolism |
| 01/21/2004 | CN1469739A Method for modulating bladder function |
| 01/21/2004 | CN1469737A Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same |
| 01/21/2004 | CN1469736A Use of a porous carrier |
| 01/21/2004 | CN1469735A Liposomal formulation of mitoxantrone |
| 01/21/2004 | CN1469733A Method for producing powdery formulations |
| 01/21/2004 | CN1469711A Treatment of helicobacter with isothiocyanates |
| 01/21/2004 | CN1468867A Soluble high branched glucose polymer and its producing process |
| 01/21/2004 | CN1468860A Manyprickle acanthopanax general saponin extractive and its medicinal composition |
| 01/21/2004 | CN1468859A Longbract cattail general flavone extractive and its prepn and use |
| 01/21/2004 | CN1468854A Prepn process and use of substituted pyrazole compound |
| 01/21/2004 | CN1468602A Application of naringin in preparing medicine for supporting treatment of SARS |
| 01/21/2004 | CN1468601A Picroside-II as one new medicine for preventing and treating allergic and inflammatory diseases |
| 01/21/2004 | CN1468600A Prepn process of glucose injection of Doxofylline |
| 01/21/2004 | CN1468599A Prepn for local treatment of tumor and chemotherapy of lymph and its prepn process |
| 01/21/2004 | CN1468598A Slow-released indapamide capsule and its prepn process |
| 01/21/2004 | CN1468597A Continuous released medical composition |
| 01/21/2004 | CN1468594A Composition containing at least one oxidative sensitive hydrophilic active ingredient through at least one maleic anhydride copolymer stabilization |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/21/2004 | CN1135234C Phytostrin and/or phytosteroidal alkanol derivative |
| 01/21/2004 | CN1135232C Piperazino derivatives as neurokinin antafonists |
| 01/21/2004 | CN1135231C 1,2,4-triazolo [4,3B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them |
| 01/21/2004 | CN1135230C Crystal modification A of 8-cyano-1-cyclopropyl-7-(1S, 6S-2.8-diazabicylo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-chinolincarboxylique |
| 01/21/2004 | CN1135229C Water soluble azoles as broad-spectrum antifungals |
| 01/21/2004 | CN1135228C N-aryloxyethyl-indoly-alkylamines for treatment of depression |
| 01/21/2004 | CN1135225C Preparation and application of pesticidal enantiomer-pure 2,4-disubstituted oxazolines |
| 01/21/2004 | CN1135224C Benzimidazole derivatives |
| 01/21/2004 | CN1135223C Aryl-substd propanolamine derivate medicine containing them and their use |
| 01/21/2004 | CN1135218C Lipid mixtures and their use |
| 01/21/2004 | CN1135110C Oil preparation for treating burn and scald |
| 01/21/2004 | CN1135108C Medicine for treating joint and soft tissue injury |
| 01/21/2004 | CN1135105C Natural physiologically active substances efficacious against fish diseases and fish feed containing the same |
| 01/21/2004 | CN1135104C Local anesthetic for external use |
| 01/21/2004 | CN1135103C Controlled release drugs delivered through sublingual or buccal administration |
| 01/20/2004 | US6680391 Treatment of skin conditions |
| 01/20/2004 | US6680386 Process for preparing 2-(4-chlorobenzoylamino)-3-[2 (1H)-quinolinon-4-yl] propionic acid |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680345 Salicylic acid salts of salmeterol |
| 01/20/2004 | US6680344 Cardiac-sparing; side effect reduction; topical |
| 01/20/2004 | US6680343 Administering gabapentin or pregabalin as analgesic for kidney stones |
| 01/20/2004 | US6680342 Monitoring the proliferation of cultured prostate cancer cells; obtain cells, incubate with quercetin, monitor adjustment in gene expression, decrease in androgen receptor gene expression indicate cell proliferation inhibitor |
| 01/20/2004 | US6680341 Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor |
| 01/20/2004 | US6680340 Anti-hypercholesterolemic drug combination |
| 01/20/2004 | US6680339 15-fluoro prostaglandins as ocular hypotensives |
| 01/20/2004 | US6680337 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/20/2004 | US6680336 Cyclic nucleotide phosphodiesterases inhibitors; antiinflammatory agents; 2,3-dioxy-4-pyrrole substituted phenyl derivatives |
| 01/20/2004 | US6680333 Imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2004 | US6680331 Administering diethyl lactams such as 3,3-diethyl-2-pyrrolidinone for inducing anesthesia or conscious sedation |
| 01/20/2004 | US6680330 Rapamycin dialdehydes |
| 01/20/2004 | US6680329 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants |
| 01/20/2004 | US6680328 Cholinergic ligands of nicotinic acetyl choline receptors for treatment of central nervous system disorders, smooth muscle contraction disorders, endocrine diseases/disorders, neurodegeneration, inflammation, pain, and drug withdrawal |
| 01/20/2004 | US6680327 Crystalline form VII of cabergoline |
| 01/20/2004 | US6680326 Antitumor agents; anticancer agents |
| 01/20/2004 | US6680322 Compounds specific to adenosine A1 receptors and uses thereof |
| 01/20/2004 | US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators |
| 01/20/2004 | US6680320 Urokinase inhibitors |
| 01/20/2004 | US6680318 Piperazinomethylbenzamides as delta-opioid receptor agonists |
| 01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
| 01/20/2004 | US6680316 Pyridazin-3-one derivatives and medicines containing the same |
| 01/20/2004 | US6680314 Azacyclooctane and heptane derivatives, their preparation and use in therapy |
| 01/20/2004 | US6680310 Methods for preventing antipsychotic-induced weight gain |
| 01/20/2004 | US6680309 Administering hypocalcemic hydroxyvitamin d compound having ahydrocarbon moiety at the c-24 position as anticarcinogenic agent |
| 01/20/2004 | US6680308 Administering n-(formyl or acetyl)-n-hydroxylamino)-alkylphosphonic acid derivative as viricide, parasiticide or fungicide |
| 01/20/2004 | US6680307 Use of ibandronate for promoting osseointegration of endoprostheses |
| 01/20/2004 | US6680306 Method for enhancing the effectiveness of cancer therapies |
| 01/20/2004 | US6680303 3′,5-difluoro-2′,3′-didehydropyrimidine nucleosides and methods of treatment therewith |
| 01/20/2004 | US6680302 Administering a 6- mercaptopurine drug to a patient having immune-mediated gastrointestinal disorder and determining a level of 6-thioguanine in the patient |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680294 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/20/2004 | US6680198 Engraftable human neural stem cells |
| 01/20/2004 | US6680135 Substrate with a photocatalytic coating |
| 01/20/2004 | US6680073 Aqueous composition containing salicylic acid, copper salt and complex, peroxide and polyhydroxyaromatic |
| 01/20/2004 | US6680071 Opioid agonist in a fast dispersing dosage form |
| 01/20/2004 | US6680070 High impact strength shape retentive material comprised of such as halogenated hydantoin and micronized polyolefin and/or polyfluorocarbon wax binder |
| 01/20/2004 | US6680067 Analgesic in admixture with injectable oil; nalbuphine free base or a pharmaceutically acceptable salt |
| 01/20/2004 | US6680062 Anti-irritating rosacea treatment |
| 01/20/2004 | US6680054 Macromolecular neuraminidase-binding compounds |
| 01/20/2004 | US6680049 Crosslsinked polymers; film forming |
| 01/20/2004 | US6679859 Amelioration of ischemic damage using synthetic oxygen carriers |
| 01/20/2004 | CA2379887C Stable tablets comprising simvastatin |
| 01/20/2004 | CA2350694C Low-irritation antiperspirant and deodorant compositions |
| 01/20/2004 | CA2310290C Composition for and method of preventing or treating breast cancer |
| 01/20/2004 | CA2308745C 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]hydrohalogenides |
| 01/20/2004 | CA2303498C Dioxocyclopentyl hydroxamic acids |
| 01/20/2004 | CA2284795C Novel pyrimidine derivatives and processes for the preparation thereof |
| 01/20/2004 | CA2274621C New nitrone derivatives, their preparation method and pharmaceutical compositions comprising them |
| 01/20/2004 | CA2273181C 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo[d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function |
| 01/20/2004 | CA2258501C Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 01/20/2004 | CA2243404C Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 01/20/2004 | CA2241247C Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles |